AMERIPRISE FINANCIAL INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 259 filers reported holding CONMED CORP in Q3 2021. The put-call ratio across all filers is 3.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$97,540,200
-31.9%
967,171
-8.2%
0.03%
-28.9%
Q2 2023$143,239,705
+2.1%
1,054,078
-22.0%
0.04%
-2.2%
Q1 2023$140,301,587
+26.5%
1,350,863
+8.0%
0.05%
+21.1%
Q4 2022$110,916,000
+0.6%
1,251,295
-9.0%
0.04%
-7.3%
Q3 2022$110,203,000
-12.5%
1,374,634
+4.6%
0.04%
-6.8%
Q2 2022$125,875,000
-31.1%
1,314,459
+6.8%
0.04%
-18.5%
Q1 2022$182,735,000
+11.4%
1,230,748
+6.4%
0.05%
+20.0%
Q4 2021$163,982,000
+22.7%
1,156,742
+13.3%
0.04%
+4.7%
Q3 2021$133,594,000
+8.4%
1,021,400
+13.8%
0.04%
+13.2%
Q2 2021$123,272,000
+25.0%
897,447
+18.8%
0.04%
+15.2%
Q1 2021$98,654,000
+107.0%
755,437
+77.5%
0.03%
+94.1%
Q4 2020$47,654,000
+48.5%
425,499
+4.3%
0.02%
+30.8%
Q3 2020$32,092,000
-0.4%
407,940
-8.8%
0.01%
-7.1%
Q2 2020$32,210,000
+167.7%
447,407
+113.0%
0.01%
+133.3%
Q1 2020$12,030,000
-48.7%
210,032
+0.1%
0.01%
-40.0%
Q4 2019$23,461,000
+17.9%
209,787
+1.4%
0.01%
+11.1%
Q3 2019$19,891,000
+11.8%
206,862
-0.5%
0.01%
+12.5%
Q2 2019$17,793,000
-10.8%
207,918
-13.3%
0.01%
-11.1%
Q1 2019$19,947,000
+27.9%
239,793
-1.3%
0.01%
+12.5%
Q4 2018$15,592,000
-13.0%
242,867
+7.4%
0.01%
+33.3%
Q3 2018$17,920,000
+14.8%
226,185
+6.0%
0.01%
-14.3%
Q2 2018$15,614,000
+52.9%
213,314
+32.3%
0.01%
+40.0%
Q1 2018$10,213,000
+31.5%
161,263
+5.8%
0.01%
+25.0%
Q4 2017$7,768,000
-4.5%
152,403
-1.7%
0.00%0.0%
Q3 2017$8,138,000
+12.8%
155,112
+9.5%
0.00%0.0%
Q2 2017$7,213,000
+24.1%
141,598
+8.2%
0.00%
+33.3%
Q1 2017$5,811,000
+5.1%
130,868
+4.5%
0.00%0.0%
Q4 2016$5,530,000
+11.9%
125,198
+1.5%
0.00%0.0%
Q3 2016$4,941,000
-17.9%
123,338
-2.2%
0.00%
-25.0%
Q2 2016$6,017,000
+17.8%
126,053
+3.5%
0.00%
+33.3%
Q1 2016$5,106,000
-2.7%
121,732
+2.2%
0.00%0.0%
Q4 2015$5,247,000
-9.8%
119,120
-2.2%
0.00%
-25.0%
Q3 2015$5,817,000
-24.2%
121,842
-7.4%
0.00%0.0%
Q2 2015$7,671,000
+17.7%
131,631
+2.0%
0.00%0.0%
Q1 2015$6,517,000
+16.1%
129,068
+3.4%
0.00%
+33.3%
Q4 2014$5,615,000
+25.3%
124,867
+2.6%
0.00%0.0%
Q3 2014$4,483,000
-74.8%
121,666
-69.8%
0.00%
-70.0%
Q2 2014$17,784,000
-51.7%
402,806
-52.5%
0.01%
-54.5%
Q1 2014$36,832,000
-31.8%
847,690
-33.3%
0.02%
-33.3%
Q4 2013$53,985,000
+37.2%
1,270,226
+9.8%
0.03%
+26.9%
Q3 2013$39,335,000
+17.9%
1,157,210
+8.3%
0.03%
+13.0%
Q2 2013$33,367,0001,068,0500.02%
Other shareholders
CONMED CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Endurant Capital Management LP 41,984$4,234,0863.80%
Ranger Investment Management 334,874$33,772,0432.24%
SECTORAL ASSET MANAGEMENT INC 114,000$11,496,9002.24%
EARNEST PARTNERS LLC 2,265,092$228,434,5281.32%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 144,376$14,560,3201.01%
EPIQ PARTNERS, LLC 10,463$1,055,1940.80%
Hood River Capital Management LLC 236,127$23,813,4080.76%
Heritage Wealth Partners, LLC 3,375$340,3690.73%
Champlain Investment Partners, LLC 943,260$95,127,7710.62%
WESTWOOD HOLDINGS GROUP INC 559,157$56,3910.53%
View complete list of CONMED CORP shareholders